Has The Time Arrived To Buy This Blue Chip Stock-XPEV

Acrobull UK Advisory Services Ltd.

January 27			2025
Name	Ticker	Sector/Industry		Market Cap	Risk Factor
Xpeng Inc.	XPEV-NYSE	Consumer Cyclical		$17.925 Billion	Medium

XPeng Inc. is a China-based company that designs, develops, manufactures, and sells smart electric vehicles. Its lineup includes the P7 and P7i four-door sports sedans, the G9 mid- to large-size smart SUV, the G6 smart coupe-style SUV, and the X9, a large seven-seat smart multi-purpose vehicle.

Recent Highlights

Vehicle Delivery- XPENG delivered 37,508 vehicles in December 2025, representing a year-over-year increase of 2%. Total annual deliveries in 2025 reached 429,445 units, representing a 126% increase over the prior year.

For the full year 2025, XPENG delivered 45,008 vehicles in overseas markets, up 96% year-over-year, and expanded its global footprint to 60 countries and regions by year-end.

Third Quarter 2025 Financial Highlights

During the third quarter of 2025, XPENG delivered a total of 116,007 vehicles, representing a significant year-over-year increase of 149.3% compared with 46,533 deliveries in the same period of 2024.

As of September 30, 2025, the company’s physical sales and service network comprised 690 stores across 242 cities. In addition, XPENG’s self-operated charging infrastructure expanded to 2,676 charging stations, including 1,623 S4 and S5 ultra-fast charging stations.

Total revenue for the third quarter of 2025 reached RMB 20.38 billion (US$2.86 billion), reflecting a 101.8% increase year over year and an 11.5% sequential increase from the second quarter of 2025.

Revenue generated from vehicle sales amounted to RMB 18.05 billion (US$2.54 billion), representing a 105.3% increase compared with the same period in 2024 and a 6.9% increase quarter over quarter.

Gross margin improved to 20.1% in the third quarter of 2025, up from 15.3% in the corresponding period of 2024 and 17.3% in the second quarter of 2025, highlighting continued operational efficiency and profitability improvements.

Stock Observation- Building on the strong performance in the third quarter of 2025, XPENG expects continued revenue growth supported by sustained demand momentum, an expanding product portfolio, and ongoing improvements in operational efficiency, positioning the company for further year-over-year and sequential revenue increases in upcoming periods.

Risk Involved- Financial performance of the company may have an impact on the company stock performance.

Considering all the factors and financials of the company Acrobull UK maintains Buy for the stock.

Disclaimer- Though our research is fundamentally and technically based on Acrobull UK only provides general advice on the stocks and it is imperative for the investors to do the risk assessment for themselves before investing as Acrobull UK would not be liable for any loss or profit arising out through the investment made by the investors on our recommendations.

It is also advisable for the investors to consult with Financial Advisor, Broker or to seek any legal assistance as the research conducted by Acrobull UK is factually based and recommendations are given in accordance with that, but it is imperative to understand that Acrobull UK does not guarantee returns.

Acrobull UK Recommendation Based on Evaluation

Current Market Price	$18.79 USD
Acrobull Recommendation	Buy
Target Price	$20.25 USD
RSI Level	42 RSI
Total Shares Outstanding	779.61 Million
Shares Held by Insiders Shares Held by Institutions Risk Factor Stop Loss	4.82% 13.37% Medium 5%